Net shares · 365d
-10.7K
0 buy · 10.7K sell
Net value · 365d
-$557.9K
$0 in · $557.9K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 10.7K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
AKRO Other·D
Chief Development Officer
—
456.6K sh · 9 lots
Own -100%
-
AKRO Other·D
Chief Development Officer
—
74.8K sh · 2 lots
Own -100%
-
AKRO Exercise·M
Chief Development Officer
$0
8.3K sh · 2 lots
Own New
-
AKRO Exercise·M
Chief Development Officer
$200.0K
8.3K sh · $24.19 avg · 2 lots
Own +12%
-
AKRO Sell·S
Chief Development Officer
$28.4K
659 sh · $43.02
Own -1%
-
AKRO Exercise·M
Chief Development Officer · 10b5-1
$0
10.0K sh
Own +8%
-
AKRO Sell·S
Chief Development Officer · 10b5-1
$529.5K
10.0K sh · $52.95 avg · 2 lots
Own -10%
-
AKRO Exercise·M
Chief Development Officer · 10b5-1
$198.7K
10.0K sh · $19.87
Own +11%
-
AKRO Grant·A
Chief Development Officer
$21.2K
890 sh · $23.87
Own +1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Dec 9, 2025 | AKRO | Other D | 456.6K9 lots | — |
| Dec 9, 2025 | AKRO | Other D | 74.8K2 lots | — |
| Nov 4, 2025 | AKRO | Exercise M | 8.3K2 lots | $0 |
| Nov 4, 2025 | AKRO | Exercise M | 8.3K2 lots | $200.0K |
| Sep 11, 2025 | AKRO | Sell S | 659 | $28.4K |
| Jul 16, 2025 | AKRO | Exercise M | 10.0K | $0 |
| Jul 16, 2025 | AKRO | Sell S | 10.0K2 lots | $529.5K |
| Jul 16, 2025 | AKRO | Exercise M | 10.0K | $198.7K |
| Jun 30, 2025 | AKRO | Grant A | 890 | $21.2K |
Buy Sell Non-market (grant · exercise · gift)
About Yale Catriona
This profile aggregates every SEC Form 4 insider transaction reported by Yale Catriona across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.